Indications for Magnetic Resonance Angiography (MRA)
MRA is indicated for noninvasive evaluation of cerebrovascular disease, including detection of carotid stenosis, intracranial steno-occlusive disease, arterial dissection, aneurysms, arteriovenous malformations, and fibromuscular dysplasia, with particular utility in patients who cannot undergo CT angiography due to renal impairment or contrast allergy. 1
Primary Clinical Indications
Cerebrovascular Disease (Stroke and TIA)
For patients with transient retinal or hemispheric neurological symptoms of possible ischemic origin, noninvasive imaging including MRA is recommended for detection of extracranial carotid and vertebral artery disease. 2, 3 This represents a Class I recommendation with the highest level of guideline support.
- MRA of the head is appropriate for evaluating intracranial steno-occlusive disease in patients presenting with TIA or stroke 1
- MRA of the neck is indicated for screening extracranial vascular disease in TIA/stroke workup, particularly for patients who are candidates for carotid endarterectomy or stenting within 48 hours of symptom onset 1
- Time-of-flight (TOF) MRA is sufficiently sensitive to screen for culprit intracranial lesions 1
When duplex ultrasonography yields equivocal or nondiagnostic results in patients with acute focal ischemic symptoms, MRA or CTA is indicated to detect carotid stenosis. 2, 3 This addresses the common clinical scenario where initial ultrasound is inconclusive.
Specific Vascular Pathologies
MRA is particularly valuable for detecting:
- Arterial dissection: MRA effectively demonstrates carotid and vertebral artery dissections, useful for both diagnosis and follow-up 4
- Intracranial aneurysms: For hemorrhagic stroke evaluation, MRA detects intracranial aneurysms, though sensitivity varies by aneurysm size 4
- Arteriovenous malformations: MRA identifies cerebral vascular malformations 4
- Fibromuscular dysplasia: A less common cause of ischemic stroke effectively visualized by MRA 4
- Venous thrombosis: MRA can detect cerebral venous thrombosis in select cases 4
- Vasculitis: Some cases of cerebral vasculitis are detectable by MRA 4
Pulsatile Tinnitus
MRA (with or without contrast) is indicated as a noninvasive alternative to screen for intracranial vascular malformations in patients with pulsatile tinnitus. 5 This is particularly useful when vascular anomalies, malformations, or dissection are suspected.
Peripheral Vascular Disease
MRA is indicated for evaluating peripheral arterial occlusive disease, particularly in patients with:
- Renal insufficiency (avoiding nephrotoxic iodinated contrast) 6, 7
- Contrast allergy 6
- Need for pre-intervention planning 6
Contrast-enhanced MRA provides more accurate imaging of extracranial vessel morphology and degree of stenosis than nonenhanced TOF techniques 4
Technical Performance Characteristics
Accuracy for Carotid Disease
Extracranial carotid stenosis detection:
- Nonenhanced MRA: mean sensitivity 93%, specificity 88% for stenosis ≥70% 4
- Contrast-enhanced MRA: sensitivity 62-91%, specificity 86-97% compared to digital subtraction angiography 4
- Contrast-enhanced MRA provides superior accuracy compared to TOF techniques 4
Intracranial stenosis detection:
- Sensitivity 60-85% for stenoses, 80-90% for occlusions 4
- Some studies report sensitivity/specificity ≥90% for stenoses >50% 4
Key Advantages Over Other Modalities
MRA is preferable to CTA when:
- Patient has renal impairment (avoiding nephrotoxic contrast) 1
- X-ray contrast allergy exists 1
- Repeat presentations require serial imaging (no ionizing radiation) 1
- Outpatient setting is desired 8
MRA is less accurate than CTA and digital subtraction angiography for steno-occlusive disease but offers noninvasive assessment without radiation exposure. 4
When MRA Should NOT Be Used
MRA is not recommended for:
- Routine screening of asymptomatic patients without risk factors for atherosclerosis 2, 3
- Evaluation of neurological disorders unrelated to focal cerebral ischemia (brain tumors, degenerative disorders, psychiatric conditions, epilepsy) 2, 3
- Routine serial imaging in patients with no atherosclerotic risk factors and no disease on initial testing 2, 3
Clinical Decision Algorithm
For symptomatic patients (TIA/stroke):
- Initial evaluation with duplex ultrasonography
- If ultrasound is equivocal/nondiagnostic → proceed to MRA or CTA
- If renal impairment or contrast allergy → MRA preferred over CTA
- If complete occlusion suggested by noninvasive imaging → consider catheter angiography to determine vessel patency for revascularization 2, 3
For follow-up of treated aneurysms:
- MRA is the preferred long-term follow-up modality for untreated and endovascularly treated intracranial aneurysms 9
- CTA remains preferred for following clipped aneurysms 9
Important Caveats
Contrast-enhanced MRA generally provides superior diagnostic quality compared to nonenhanced techniques, shortening exam duration and improving vessel visualization 4. However, noncontrast MRA of the neck tends to overestimate carotid stenosis degree, particularly in high-grade stenosis 1.
MRA accuracy is less than CTA and digital subtraction angiography for steno-occlusive disease, but its noninvasive nature and lack of radiation make it valuable for serial monitoring and patients with contraindications to other modalities 4.